Global conglomerate GlaxoSmithKline (GSK), which owns the beverage brand Lucozade, has announced its plans to launch the energy drink in the US.
According to The Times, the drugs giant is currently in “advanced” talks with a prospective distributor to introduce the range to US markets.
The move will pitch Lucozade, which had British sales of around £376 million in 2009, against Coca Cola’s Powerade and PepsiCo’s Gatorade products.
John Clarke, head of consumer healthcare with the firm, told the newspaper that GSK was eager to push the drink into new markets as it increases its focus on consumer healthcare.
He added that a Chinese distribution deal had recently led to a launch in Asia, while plans are still in development for Mexico and Brazil.
Meanwhile, research by scientists at Harvard Medical School has revealed that if the US government rolls out its plans for a tax hike on sugary drinks, sales could be damaged.